Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Biomaterials. 2013 Apr 8;34(21):5149–5162. doi: 10.1016/j.biomaterials.2013.03.044

Figure 3.

Figure 3

Comparison of combined Dox and chi-p53 FD treatment with Dox FD or chi-p53 FD treatment on growth inhibition of HepG2 cells. Data represent mean ± standard deviation, n = 9.